Corrigendum: The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience.
Front Oncol
; 14: 1412472, 2024.
Article
em En
| MEDLINE
| ID: mdl-38887239
ABSTRACT
[This corrects the article DOI 10.3389/fonc.2024.1331128.].
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article